Mutations in the tumour suppressor gene TP53 are more frequent in BRCA1-associated breast tumours than in sporadic cases (Greenblatt et al, 2001), mainly because of a selective increase in protein-truncating TP53 mutations (Holstege et al, 2009; Manié et al, 2009). Here, BRCA1 is linked to breast neoplasm.